Related Experiment Videos

Gentamicin- and methicillin-resistant Staphylococcus aureus: phenotypic and genotypic characterization of three

W H Traub1, B Leonhard, D Bauer

  • 1Institut für Medizinische Mikrobiologie und Hygiene, Universität des Saarlandes, Homburg/Saar, Germany.

Chemotherapy
|January 1, 1996
PubMed

Insights

This study identified three distinct phenotypes among nineteen methicillin-resistant Staphylococcus aureus (MRSA) isolates, differing in toxin production and nitrocefin hydrolysis. All MRSA strains exhibited a capsule and consistent resistance/susceptibility patterns to key antibiotics.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Bacterial Pathogenesis

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) is a significant public health concern due to its resistance to multiple antibiotics.
  • Understanding the phenotypic diversity within MRSA strains is crucial for effective treatment and infection control.
  • Staphylococcus aureus can produce various virulence factors, including toxins and capsules, which influence its pathogenicity.

Purpose of the Study:

  • To characterize the phenotypic and genotypic features of gentamicin- and methicillin-resistant Staphylococcus aureus (MRSA) isolates.
  • To investigate the relationship between antibiotic resistance, toxin production, and capsule formation in MRSA.
  • To identify distinct phenotypes within a collection of MRSA isolates.

Main Methods:

  • Phenotypic characterization of nineteen MRSA isolates.
  • Assessment of nitrocefin hydrolysis for beta-lactamase activity.
  • Detection of staphylococcal enterotoxin A (SEA) and toxic shock syndrome toxin-1 (TSST-1) production.
  • Antibiotic susceptibility testing using a panel of representative antimicrobial agents.
  • Evaluation of capsule production in all isolates.

Main Results:

  • Nineteen MRSA isolates were classified into three distinct phenotypes based on nitrocefin hydrolysis and toxin production (SEA and/or TSST-1).
  • All isolates produced a capsule, suggesting its common role in these MRSA strains.
  • Consistent susceptibility was observed for coumermycin, nitrofurantoin, novobiocin, trimethoprim, trimethoprim-sulfamethoxazole, teicoplanin, and vancomycin.
  • All isolates demonstrated resistance to co-amoxiclav, ciprofloxacin, clarithromycin, gentamicin, methicillin, norfloxacin, ofloxacin, oxacillin, and polymyxin B.

Conclusions:

  • MRSA isolates exhibit phenotypic heterogeneity, particularly in toxin profiles and beta-lactamase activity.
  • Capsule production is a common feature among these gentamicin- and methicillin-resistant strains.
  • The consistent resistance and susceptibility patterns highlight specific antibiotic vulnerabilities and strengths in managing these MRSA phenotypes.

Related Concept Videos